Literature DB >> 28922162

Sphingolipids in Alzheimer's Disease and Related Disorders.

Pilar Martinez Martinez1, Michelle M Mielke2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28922162     DOI： 10.3233/JAD-170735

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN： 1387-2877            Impact factor:   4.472


× No keyword cloud information.
  3 in total

Review 1.  Exploring Sphingolipid Implications in Neurodegeneration.

Authors:  Alice V Alessenko; Elisabetta Albi
Journal:  Front Neurol       Date:  2020-05-21       Impact factor: 4.003

Review 2.  Sphingolipidomics in Translational Sepsis Research-Biomedical Considerations and Perspectives.

Authors:  Ralf A Claus; Markus H Graeler
Journal:  Front Med (Lausanne)       Date:  2021-01-20

Review 3.  The Involvement of Lactosylceramide in Central Nervous System Inflammation Related to Neurodegenerative Disease.

Authors:  Wen Yu; Jun Ying; Xifeng Wang; Xing Liu; Tiancheng Zhao; Sungtae Yoon; Qingcui Zheng; Yang Fang; Danying Yang; Fuzhou Hua
Journal:  Front Aging Neurosci       Date:  2021-07-19       Impact factor: 5.750
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.